Sean E. Bland, JD, reviews the USPSTF guidelines as support to access HIV PrEP therapy and Ryan Bitton, PharmD, MBA, shares a payer perspective on the implications of these guidelines. Ryan Haumschild ...

A new Canadian guideline on HIV prevention emphasizes the patient’s role in decisions related to pre-exposure prophylaxis (PrEP) and postexposure prophylaxis (PEP) prescriptions. It also highlighted ...

Frank J. Palella, MD, shares a provider perspective for steps to take in accordance with USPSTF guidelines for HIV PrEP to get patients appropriate medications, and Ryan Bitton, PharmD, MBA, shares a ...

Multiple pre-exposure (PrEP) and postexposure (PEP) treatments are now available to prevent HIV infection. An updated Canadian guideline published in CMAJ (Canadian Medical Association Journal) ...

The CDC made a strong recommendation based on a high certainty of evidence to use the long-acting injectable lenacapavir (Yeztugo) for HIV pre-exposure prophylaxis (PrEP), but will that ensure the ...

World Health Organisation (WHO) has released new guidelines for the use of long-acting cabotegravir (CAB-LA) as pre-exposure prophylaxis (PrEP) for HIV. Director of WHO’s Global HIV, Hepatitis and ...

A coalition of doctors across Canada is releasing a new guideline for prescribing medications that can prevent HIV infection, with a strong focus on increasing the promotion and awareness of the ...

Nearly one in three gay and bisexual men who were diagnosed with HIV at UK sexual health clinics didn't meet the criteria for "high risk" that would signal to a clinician that they would be good ...

Though an antiretroviral medication called PrEP provides near-perfect protection against HIV, patients must often surmount ...